A thorough QTC study to assess the effect of Cotadutide on cardiac repolarization in healthy participants

Trial Identifier: D5671C00010
Sponsor: AstraZeneca
NCTID:: NCT05668936
Start Date: January 2023
Primary Completion Date: March 2023
Study Completion Date: March 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations